NCT00132067 2019-07-23Vorinostat in Treating Patients With Recurrent or Persistent Ovarian Epithelial or Primary Peritoneal Cavity CancerNational Cancer Institute (NCI)Phase 2 Completed60 enrolled
NCT00772798 2008-10-15A Phase I/II Study of Paclitaxel Plus Carboplatin Plus Vorinostat in Recurrent Ovarian CancerHerlev HospitalPhase 2 Unknown70 enrolled